Blue Granite Capital’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q2
Sell
-3,000
Closed -$145K 112
2017
Q1
$145K Hold
3,000
0.09% 86
2016
Q4
$120K Buy
+3,000
New +$120K 0.09% 84